Finance

Lists
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६५५.००
-०.६६%
(-१७.६०) 1D
नोभेम्बर १६, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAXO...
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
१३ मिनेट पहिले
What's dragging down the S&P 500? Apple in focus
Investing.com
Investing.com
·
२५ मिनेट पहिले
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Last report
२०२६ नोभेम्बर ३
Fiscal period
Q2 2027
₹ १९.८३ / ₹ १६.५०
+२०.१८%beat
Revenue / Est. (INR)
११.८४ अरब / १०.७९ अरब
+९.६६%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१०.४१ अरब
९.९५ अरब
९.३८ अरब
११.८४ अरब
Cost of goods sold
३.६४ अरब
३.६९ अरब
३.२८ अरब
४.४४ अरब
Cost of revenue
३.६४ अरब
३.६९ अरब
३.२८ अरब
४.४४ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.५२ अरब
२.९५ अरब
१.५९ अरब
१.७० अरब
Operating expense
३.२६ अरब
२.८४ अरब
३.३१ अरब
३.५२ अरब
Total operating expenses
६.९० अरब
६.५३ अरब
६.५९ अरब
७.९७ अरब
Operating income
३.५१ अरब
३.४३ अरब
२.८० अरब
३.८७ अरब
Other non operating income
३२.१२ करोड
-१.०९ अरब
४३.७६ करोड
७२.७८ करोड
EBT including unusual items
४.०० अरब
३.७३ अरब
३.२२ अरब
४.५९ अरब
EBT excluding unusual items
३.८२ अरब
२.९४ अरब
३.२२ अरब
४.५९ अरब
Income tax expense
१.०४ अरब
९५.२४ करोड
८५.२७ करोड
१.२३ अरब
Effective tax rate
२६.०८%
२५.५३%
२६.४४%
२६.८८%
Other operating expenses
१.५४ अरब
-२३.६८ करोड
१.५६ अरब
१.६७ अरब
Net income
२.९६ अरब
२.७८ अरब
२.३७ अरब
३.३६ अरब
Net profit margin
२८.३९%
२७.९२%
२५.२७%
२८.३८%
Earnings per share
-
-
१४.००
१९.८३
Interest and investment income
-
६५.७३ करोड
-
-
Interest expense
-१.१९ करोड
-६१.२३ लाख
-९७.०० लाख
-४९.०० लाख
Net interest expenses
-१.१९ करोड
६५.१२ करोड
-९७.०० लाख
-४९.०० लाख
Depreciation and amortization charges
२०.३२ करोड
१३.१७ करोड
१५.८४ करोड
१५.०२ करोड
EBITDA
३.६१ अरब
३.५२ अरब
२.८९ अरब
४.०२ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू